Adrenergic beta-2 Receptor Antagonists
"Adrenergic beta-2 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and block the activation of ADRENERGIC BETA-2 RECEPTORS.
| Descriptor ID |
D058672
|
| MeSH Number(s) |
D27.505.519.625.050.200.200.200 D27.505.696.577.050.200.200.200
|
| Concept/Terms |
Adrenergic beta-2 Receptor Antagonists- Adrenergic beta-2 Receptor Antagonists
- Adrenergic beta 2 Receptor Antagonists
- Adrenergic beta2-Antagonists
- Adrenergic beta2 Antagonists
- beta2-Antagonists, Adrenergic
- beta-2 Adrenergic Blocking Agents
- beta 2 Adrenergic Blocking Agents
- Adrenergic beta-2 Antagonists
- Adrenergic beta 2 Antagonists
- Antagonists, Adrenergic beta-2
- beta-2 Antagonists, Adrenergic
- Adrenergic beta-2 Receptor Blockers
- Adrenergic beta 2 Receptor Blockers
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-2 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-2 Receptor Antagonists".
This graph shows the total number of publications written about "Adrenergic beta-2 Receptor Antagonists" by people in this website by year, and whether "Adrenergic beta-2 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 2 | 1 | 3 |
| 2017 | 0 | 3 | 3 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenergic beta-2 Receptor Antagonists" by people in Profiles.
-
The effects of ?1 and ?1+2 adrenergic receptor blockade on the exercise-induced mobilization and ex vivo expansion of virus-specific T cells: implications for cellular therapy and the anti-viral immune effects of exercise. Cell Stress Chaperones. 2020 11; 25(6):993-1012.
-
?2-Adrenoceptor signaling in airway epithelial cells promotes eosinophilic inflammation, mucous metaplasia, and airway contractility. Proc Natl Acad Sci U S A. 2017 10 24; 114(43):E9163-E9171.
-
Vigorous exercise mobilizes CD34+ hematopoietic stem cells to peripheral blood via the ?2-adrenergic receptor. Brain Behav Immun. 2018 02; 68:66-75.
-
Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk. Heart. 2017 10; 103(19):1536-1542.
-
Complementary anti-inflammatory effects of a ?-blocker and a corticosteroid in an asthma model. Naunyn Schmiedebergs Arch Pharmacol. 2012 Feb; 385(2):203-10.
-
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD. Eur Respir J. 2011 Oct; 38(4):797-803.
-
The effects of acute and chronic nadolol treatment on ?2AR signaling in HEK293 cells. Naunyn Schmiedebergs Arch Pharmacol. 2011 Feb; 383(2):209-16.
-
Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling. Cardiovasc Res. 2009 Dec 01; 84(3):452-60.
-
The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment. BMC Pharmacol. 2007 Dec 20; 7:16.
-
Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest. 2007 Sep; 117(9):2431-44.